On May 22, 2025, Maravai LifeSciences Holdings, Inc. held its 2025 Annual Meeting, where shareholders voted to elect directors, ratify Ernst & Young LLP as auditors for 2025, and approve executive compensation. A total of 231,686,324 shares were represented at the meeting.